Thriving in lockdown

15 May 2020
| By Industry |
image
image
expand image

While stockmarkets have seen the fastest rebound in history since lows on 23 March, the economic data has been dire. According to the Reserve Bank of Australia, national output is likely to fall by around 10% over the first half of 2020, with most of this decline taking place in the June quarter and unemployment is likely to be around 10% by June.

So, what is driving the rally? The most obvious rationale is the US$8 trillion ($12.4 trillion) plus of monetary and fiscal stimulus from global governments and central banks to support their economies. The response has been larger and faster than the Global Financial Crisis (GFC). The S&P 500 for example, is up 24% since its 23 March lows and although markets are still 15% behind the market peak on 19 February, given the scale of the pandemic and impact on supply chains many are asking if the rally can last.

For active investors, the opportunity set is ripe. During this period of economic uncertainty, the process to select companies for a portfolio is focused on which companies will not only thrive but survive the lockdown period. Three areas of current focus include: Cyclical rebounds: Many industries have been decimated and those companies with strong operating cashflow, sufficient liquidity and manageable debt levels are more likely to survive.  Determining which companies will rally when the cycle turns can provide an attractive source of alpha.

Access to capital: With limited cashflow due to the lockdown restrictions many companies are raising equity. Some of these offers are less attractive than others but this environment also offers active investors the opportunity to pick up quality companies at a significant discount.

The yield trap: Stocks that have traditionally been the hunting ground for yield-hungry investors could look very different in the medium-term. With many companies deferring or cutting dividends, further analysis of balance sheet strength and cashflow is needed to assess which companies can produce reliable dividends in the future.

IDENTIFYING CYCLICAL REBOUNDS

Contrary to other economic downturns such as the GFC and Tech Wreck which have been dissected for clues on the potential path forward for the current crisis; this time there are sectors of the economy that have not only slowed but have ground to a halt. For sectors such as tourism, retail and aviation recent events may accelerate trends that would otherwise have taken years to eventuate such as the increasing trend towards online transactions and the move away from cash payments.  

For some of these businesses cashflow has gone negative due to refunds for holidays that cannot be taken. Therefore, it is unsurprising that many businesses in these categories have seen their share price falls exceed the index. Some will not survive, others will need an injection of capital and others should perform well when restrictions are lifted. Fund managers are actively assessing which companies’ earnings are likely to turn around faster than the market is expecting. In many cases, it is dependent on consumer behaviour and what households will spend money on once lockdown restrictions are lifted. 

The tourism sector has been one of the heaviest hit by the pandemic and Qantas has grounded much of its fleet and furloughed most of its staff. Active managers are assessing whether Qantas has enough liquidity to withstand the lockdown period, what history tells us about previous pandemics regarding consumer behaviour and how well Qantas can manage costs. 

Virgin Australia has entered voluntary administration and could pare back its domestic network and close its international operations if it emerges. This could give Qantas more domestic monopoly routes and reduce competition for international routes. 

Qantas has a strong balance sheet, entering this crisis with $2 billion in cash, $1 billion undrawn debt facilities and $4.5 billion of unencumbered aircraft. With politicians already talking about relaxing international restrictions with New Zealand preceded by the opening of domestic routes, conditions are improving. While the recovery timeline is uncertain, what occurred during the SARS outbreak could provide some insights into consumer behaviour whereby domestic travel improved before international resumed.

COMPANIES WITH ACCESS TO CAPITAL

The impact of the lockdown on corporate cashflows has led an increasing number of companies to tap the market for capital. In April 2020 alone, Australian companies raised over $13 billion of equity. For some, this will ensure their survival, for others it is an effort to shore up their balance sheets as falling revenue impacts their bottom line. 

Stockpickers must sift through these offers and consider whether they represent an opportunity to pick up shares in companies that they have long coveted but previously considered too expensive, or whether they should give it a wide berth based on company fundamentals or for portfolio construction reasons. 

In addition, at the end of March emergency capital raising relief rules were introduced which allows issuers to issue 25% of new shares provided placements are accompanied by a share purchase plan at the same or a lower price. In these circumstances, investors can buy shares at a substantial discount. Although these capital raisings dilute existing shareholders, they provide liquidity, a stronger balance sheet and better survival prospects for issuers.  

Cochlear has a dominant position in designing and manufacturing medical devices for profoundly deaf people. In late March, Cochlear announced an $880 million capital raising at $140 a share. When markets peaked on 19 February, their share price was trading at $251, but the lockdown induced by COVID-19 led to a suspension of elective surgeries. 

Accessing these types of offers is not always easy and the majority are taken up by institutional investors (including active fund managers) who can provide the quantum of support to ensure that the raising is well supported. Furthermore, equity raisings that receive strong demand often are only available to existing shareholders. Active fund managers view capital raises as an opportunity to increase their holding in companies that they consider good quality. 

If Cochlear can resume their trajectory once global lockdowns end and the backlog of surgeries provides immediate as well as long-term revenue, investors in the equity raise could receive outsize returns.

THE YIELD TRAP

With the collapse of company earnings at least in the short-term, it is not surprising that many corporates have announced dividend cuts or deferrals. Australian companies pay out over 70% of their earnings on average, a much greater proportion than their global counterparts due to Australia’s imputation system. As such, the impact of dividend cuts is likely to be greater with expectations for dividends from Australian companies at the lowest level since 2008.

Many investors faced with low deposit rates and low bond yields look to these dividends and franking credits as a source of income. Traditionally the banking sector has provided attractive yields, paying out up to 90% of their earnings but this is changing with NAB becoming the first of the big four banks to announce a large dividend cut.

Investors looking for income will need to look more broadly across sectors going forward. The reliability of this income is one of the factors managers consider when choosing stocks to add to their portfolio. If growth and acquisition opportunities are low, paying out dividends to shareholders is an efficient use of capital.

The uncertain outlook for the Australian economy is putting pressure on bank dividends as some companies seek to preserve capital. When Australia emerges from the current recession the outlook for the banks is likely to be closely tied to the fortunes of the Australian economy. 

It must be factored the Australian Prudential Regulation Authority (APRA) provided the following guidance in April encouraging reduced distributions: “During this period, APRA expects that authorised deposit-taking institutions and insurers will seriously consider deferring decisions on the appropriate level of dividends until the outlook is clearer. However, where a board is confident they are able to approve a dividend before this, on the basis of robust stress testing results that have been discussed with APRA, this should nevertheless be at a materially-reduced level”.

How fast the Australian economy recovers will determine when those businesses and mortgage holders who have received deferral of interest will resume payments and when businesses look to grow and need credit again. 

This assessment of future earnings combined with an analysis of company cashflows and balance sheets is needed to determine the prospects for dividend yields looking forward.  

Sinead Rafferty is investment specialist at Fidante Partners.

Read more about:

AUTHOR

 

Recommended for you

 

MARKET INSIGHTS

sub-bg sidebar subscription

Never miss the latest news and developments in wealth management industry

Squeaky'21

My view is that after 2026 there will be quite a bit less than 10,000 'advisers' (investment advisers) and less than 100...

1 week 1 day ago
Jason Warlond

Dugald makes a great point that not everyone's definition of green is the same and gives a good example. Funds have bee...

1 week 1 day ago
Jasmin Jakupovic

How did they get the AFSL in the first place? Given the green light by ASIC. This is terrible example of ASIC's incompet...

1 week 2 days ago

AustralianSuper and Australian Retirement Trust have posted the financial results for the 2022–23 financial year for their combined 5.3 million members....

9 months 2 weeks ago

A $34 billion fund has come out on top with a 13.3 per cent return in the last 12 months, beating out mega funds like Australian Retirement Trust and Aware Super. ...

9 months ago

The verdict in the class action case against AMP Financial Planning has been delivered in the Federal Court by Justice Moshinsky....

9 months 2 weeks ago

TOP PERFORMING FUNDS

ACS FIXED INT - AUSTRALIA/GLOBAL BOND